CB-Lin Tablet

CB-Lin Tablet is a dopamine agonist. It is used for the treatment of a high level of prolactin. It is also helpful in stopping breast milk production in cases of stillbirth, abortion, or miscarriage.

CB-Lin Tablet should be taken with food, but take it at the same time to get the most benefit. It should be taken as your doctor's advice. The dose and how often you take it depends on what you are taking it for. Your doctor will decide how much you need to improve your symptoms. Swallow the tablets whole with a drink of water. You should take this medicine for as long as it is prescribed for you.

The most common side effects of this medicine include nausea, headache, dizziness, and low blood pressure. If these bother you or appear serious, let your doctor know. There may be ways of reducing or preventing them. To overcome dizziness, you must avoid driving or rise slowly from sitting or lying position.

Before taking this medicine, tell your doctor if you have ever had high blood pressure after birth, or had heart disease. Tell your doctor if you are pregnant, planning pregnancy, or breastfeeding. Your doctor should also know about all other medicines you are taking as many of these may make this medicine less effective or change the way it works. Your doctor may check blood pressure regularly while taking this medicine.

• Treatment of High levels of prolactin

Treatment of High levels of prolactin
Prolactin is a hormone that helps in the growth and development of breasts and also causes milk secretion in females. CB-Lin Tablet helps stop breast milk secretion in females who have had a stillbirth, miscarriage, or abortion. It acts on a chemical in the brain, dopamine, that is responsible for these high levels of prolactin and stops milk secretion.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Caberlactin

• Nausea
• Constipation
• Dizziness
• Fatigue
• Headache
• Vomiting
• Vertigo
• Abdominal pain
• Breast pain
• Sleepiness
• Valvulopathy and related disorders
• Dyspepsia
• Gastritis
• Weakness
• Depression
• Postural hypotension (low blood pressure)
• Hot flushes

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. CB-Lin Tablet is to be taken with food.

CB-Lin Tablet works by decreasing the release of prolactin, a hormone that stimulates breast milk production. This stops the production of breast milk in case of stillbirth, abortion or miscarriage.

• CB-Lin Tablet is used to treat conditions such as infertility or abnormal production of breast milk (galactorrhoea) caused due to excess production of a natural hormone called prolactin.
• To lower the chance of feeling dizzy or passing out, rise slowly if you have been sitting or lying down.
• Do not take CB-Lin Tablet if you are breastfeeding.
• Take it with or after food to avoid side effects such as nausea or indigestion.
• Be cautious while driving or doing anything that requires concentration as CB-Lin Tablet can cause dizziness and sleepiness.
• Regular monitoring of blood pressure may be advised during treatment with CB-Lin Tablet.

Parker KL, Schimmer BP. Introduction To Endocrinology: The Hypothalamic-Pituitary Axis. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1114-15.

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 176-709.

Mayo Clinic. Cabergoline. [Accessed 03 Apr. 2019] (online) Available from:

Cabergoline. Sandwich, Kent: Pfizer Limited; 1996 [revised May 2018].[Accessed 22 Jan. 2019] (online) Available from:

Cabergoiline. New York, New York: Pfizer; 2014. [Accessed 03 Apr. 2019] (online) Available from:

Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198. [Accessed 03 Apr. 2019] (online) Available from: